文献速递胃肠外科

机器人胃切除术与腹腔镜胃切除术治疗胃癌的短期结局:一项随机临床试验

Short-term Outcomes of Robotic Gastrectomy vs Laparoscopic Gastrectomy for Patients With Gastric Cancer: A Randomized Clinical Trial.
PubMed 文献 · JAMA Surg · 2021-01-01

这项3期前瞻性优效性随机临床试验纳入241例可切除胃癌患者,比较机器人胃切除术(RG)与腹腔镜胃切除术(LG)的短期结局。主要终点腹腔内感染性并发症发生率无显著差异(LG组8.5% vs RG组6.2%)。但LG组总体并发症(≥II级)和严重并发症(≥IIIa级)发生率均显著高于RG组。

要点

  • RG与LG的腹腔内感染性并发症发生率无显著差异。

核心结论

  • 对于胃癌患者,RG相比LG并未降低腹腔内感染性并发症的发生率。

研究设计与样本

  • 3期前瞻性优效性随机临床试验,2018年4月1日至2020年10月31日纳入241例可切除胃癌(临床I-III期)患者。
  • 改良意向治疗人群236例(男性150例[63.6%],平均年龄70.8[10.7]岁),符合方案人群用于并发症分析(LG组117例,RG组113例)。

主要发现

  • 腹腔内感染性并发症发生率在符合方案人群中LG组为10/117(8.5%),RG组为7/113(6.2%),无显著差异。
  • LG组122例中2例(1.6%)中转开腹,RG组119例中4例(3.4%)中转开腹或腹腔镜,无显著差异。

临床怎么用

  • RG可作为胃癌微创手术的一种选择,但预期不降低腹腔内感染性并发症。
  • RG可能与较低的总体和严重术后并发症发生率相关,需结合患者情况和资源选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Robotic gastrectomy (RG) for gastric cancer may be associated with decreased incidence of intra-abdominal infectious complications, including pancreatic fistula, leakage, and abscess. Prospective randomized clinical trials comparing laparoscopic gastrectomy (LG) and RG are thus required. OBJECTIVE: To compare the short-term surgical outcomes of RG with those of LG for patients with gastric cancer. DESIGN, SETTING, AND PARTICIPANTS: In this phase 3, prospective superiority randomized clinical trial of RG vs LG regarding reduction of complications, 241 patients with resectable gastric cancer (clinical stages I-III) were enrolled between April 1, 2018, and October 31, 2020. INTERVENTIONS: LG vs RG. MAIN OUTCOMES AND MEASURES: The primary end point was the incidence of postoperative intra-abdominal infectious complications. Secondary end points were incidence of any complications, surgical results, postoperative courses, and oncologic outcomes. The modified intention-to-treat population excluded patients who had been randomized and met the postrandomization exclusion criteria. There was also a per-protocol population for analysis of postoperative complications. RESULTS: This study enrolled 241 patients, with 236 patients in the modified intention-to-treat population (150 men [63.6%]; mean [SD] age, 70.8 [10.7] years). There was no significant difference in the incidence of intra-abdominal infectious complications (per-protocol population: 10 of 117 [8.5%] in the LG group vs 7 of 113 [6.2%] in the RG group). Of 241 patients, 122 were randomly assigned to the LG group, and 119 patients were randomly assigned to the RG group. Two of the 122 patients (1.6%) in the LG group converted from LG to open surgery, and 4 of 119 patients (3.4%) in the RG group converted from RG to open or laparoscopic surgery, with no significant difference. Finally, 117 patients in the LG group completed the procedure, and 113 in the RG group completed the procedure; these populations were defined as the per-protocol population. The overall incidence of postoperative complications of grade II or higher was significantly higher in the LG group (23 [19.7%]) than in the RG group (10 [8.8%]) (P = .02). Even in analysis limited to grade IIIa or higher, the complication rate was still significantly higher in the LG group (19 [16.2%]) than in the RG group (6 [5.3%]) (P = .01). CONCLUSIONS AND RELEVANCE: This study found no reduction of intra-abdominal infectious complications with RG compared with LG for gastric cancer. TRIAL REGISTRATION: umin.ac.jp/ctr Identifier: UMIN000031536.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Ojima T, Nakamura M, Hayata K, et al. Short-term Outcomes of Robotic Gastrectomy vs Laparoscopic Gastrectomy for Patients With Gastric Cancer: A Randomized Clinical Trial. JAMA Surg. 2021. PMID: 34468701. doi:10.1001/jamasurg.2021.3182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。